While the constitutive activation of the FGFR2 kinase through Shootin1-mediated dimerization is a clear oncogenic mechanism, the unique presence of Shootin1’s actin-modulating domains (i.e., PRR, WH2, FAB) within the chimeric protein opens avenues for discussions regarding its expanded role in cancer progression. The gene discussed is SHTN1; the disease is cancer.